Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment
- PMID: 11642746
- DOI: 10.14670/HH-16.1275
Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment
Abstract
Chronic hepatitis C virus (HCV) infection is frequently associated with a variety of autoimmune phenomenons. Mixed cryoglobulinemia (MC) appears in up to 50% of chronic HCV-infected patients. Cryoglobulins consist of immunoglobulin complexes precipitating in vitro when cooled below body temperature. In most cases IgM with rheumatoid factor activity is found in cryoprecipitates which could lead to vasculitis induced by the deposition of immnuocomplexes in small vessels. This vasculitis is thought to cause clinical symptoms called Meltzer's triad. This triad is represented by purpura, arthralgia and weakness. One third of patients suffering from HCV-associated mixed cryoglobulinemia are developing typical symptoms during their course of disease. The striking association between HCV infection and MC has conduced to the hypothesis that HCV is of major importance in the production of MC with followed vasculitis. Both hepatrophism and lymphotrophism have been reported for the hepatitis C virus. Infection of B-cells by HCV could probably lead to a bcl-2 translocation and immunoglobulin gene rearrangement which results in clonal lymphoproliferation and in synthesis of monoclonal IgM with rheumatoid factor activity. These IgM form immunocomplexes with IgG in the cold, which are finally responsible for the described vasculitis. Histopathological changes of the liver are dominated by chronic HCV infection. The majority of times mild activity of hepatitis or mild fibrosis could be found. Nevertheless, cirrhosis is more often found in HCV-infected patients suffering from MC compared to patients without MC. Conventional treatment of MC is aimed to reduce circulating immune complexes by immunosupression and plasmapheresis. With the emerging concept of a viral pathogenesis the therapeutic approach has changed during the last decade. Interferon treatment of MC, particularly of HCV-associated MC is well established nowadays.
Similar articles
-
The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection.Springer Semin Immunopathol. 1997;19(1):111-29. doi: 10.1007/BF00945029. Springer Semin Immunopathol. 1997. PMID: 9266635 Review.
-
Cryoglobulinemia.Hematology Am Soc Hematol Educ Program. 2005:368-72. doi: 10.1182/asheducation-2005.1.368. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304405
-
[Hepatitis-C-virus-associated cryoglobulinemia. Pathogenesis, diagnosis and treatment].Med Klin (Munich). 2002 Oct 15;97(10):601-8. doi: 10.1007/s00063-002-1201-5. Med Klin (Munich). 2002. PMID: 12386793 Review. German.
-
Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC.Ann Med Interne (Paris). 2000 Feb;151(1):20-9. Ann Med Interne (Paris). 2000. PMID: 10761559 Review.
-
Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates.Z Gastroenterol. 1995 Nov;33(11):643-50. Z Gastroenterol. 1995. PMID: 8600660
Cited by
-
Cryoglobulinemia Leading to the Diagnosis of Low Grade Serous Ovarian Carcinoma.J Community Hosp Intern Med Perspect. 2023 Nov 4;13(6):13-16. doi: 10.55729/2000-9666.1247. eCollection 2023. J Community Hosp Intern Med Perspect. 2023. PMID: 38596563 Free PMC article.
-
Stroke and limb ischaemia in hepatitis C virus-related cryoglobulinaemia.Ir J Med Sci. 2004 Jan-Mar;173(1):57. doi: 10.1007/BF02914527. Ir J Med Sci. 2004. PMID: 15732239 No abstract available.
-
Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies.Gastroenterol Hepatol (N Y). 2007 Sep;3(9):695-703. Gastroenterol Hepatol (N Y). 2007. PMID: 21960882 Free PMC article.
-
Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study.Medicine (Baltimore). 2013 Sep;92(5):245-256. doi: 10.1097/MD.0b013e31829d2abc. Medicine (Baltimore). 2013. PMID: 23982056 Free PMC article.
-
The prevalence of HCV antibodies in skin disease patients in Saudi Arabia.Saudi Pharm J. 2010 Jan;18(1):35-9. doi: 10.1016/j.jsps.2009.12.003. Epub 2009 Dec 24. Saudi Pharm J. 2010. PMID: 23960718 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical